NxStage Medical is a medical technology company that develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. Co. conducts its operations in three segments: System One, in which Co. sells and rents the System One and PureFlow SL dialysate preparation equipment, and sells disposable products in the home and critical care markets; In-Center, in which Co. sells blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease patients at dialysis clinics, and needles for apheresis; and Services, which includes dialysis services provided to patients at Co.'s NxStage Kidney Care dialysis centers. The NXTM average annual return 10 years is shown above.
The Average Annual Return on the NXTM average annual return 10 years page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether NXTM average annual return 10 years or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the NXTM average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|
Video: Don't Forget Dividends in Average Annual Return!
